138 related articles for article (PubMed ID: 18205192)
1. The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation.
Perera S; Bapat B
Hum Mutat; 2008 Feb; 29(2):332. PubMed ID: 18205192
[TBL] [Abstract][Full Text] [Related]
2. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of MLH1 missense variants identified in Lynch syndrome patients.
Andersen SD; Liberti SE; Lützen A; Drost M; Bernstein I; Nilbert M; Dominguez M; Nyström M; Hansen TV; Christoffersen JW; Jäger AC; de Wind N; Nielsen FC; Tørring PM; Rasmussen LJ
Hum Mutat; 2012 Dec; 33(12):1647-55. PubMed ID: 22753075
[TBL] [Abstract][Full Text] [Related]
4. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
[TBL] [Abstract][Full Text] [Related]
6. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
7. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
8. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
9. Influence of eight unclassified missense variants of the MLH1 gene on Lynch syndrome susceptibility.
Fan Y; Chen J; Wang W; Wu P; Zhi W; Xue B; Zhang W; Wang Y
Biochem Genet; 2012 Feb; 50(1-2):84-93. PubMed ID: 21952876
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
11. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
[TBL] [Abstract][Full Text] [Related]
12. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive functional assessment of MLH1 variants of unknown significance.
Borràs E; Pineda M; Brieger A; Hinrichsen I; Gómez C; Navarro M; Balmaña J; Ramón y Cajal T; Torres A; Brunet J; Blanco I; Plotz G; Lázaro C; Capellá G
Hum Mutat; 2012 Nov; 33(11):1576-88. PubMed ID: 22736432
[TBL] [Abstract][Full Text] [Related]
14. A novel interaction between human DNA polymerase eta and MutLalpha.
Kanao R; Hanaoka F; Masutani C
Biochem Biophys Res Commun; 2009 Nov; 389(1):40-5. PubMed ID: 19703417
[TBL] [Abstract][Full Text] [Related]
15. DNA mismatch repair and colon cancer.
Marra G; Jiricny J
Adv Exp Med Biol; 2005; 570():85-123. PubMed ID: 18727499
[No Abstract] [Full Text] [Related]
16. [Homologs of MutS and MutL during mammalian meiosis].
Santucci-Darmanin S; Paquis-Flucklinger V
Med Sci (Paris); 2003 Jan; 19(1):85-91. PubMed ID: 12836196
[TBL] [Abstract][Full Text] [Related]
17. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
18. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.
Plotz G; Welsch C; Giron-Monzon L; Friedhoff P; Albrecht M; Piiper A; Biondi RM; Lengauer T; Zeuzem S; Raedle J
Nucleic Acids Res; 2006; 34(22):6574-86. PubMed ID: 17135187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
